Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site.

× No keyword cloud information.

5 in total

1. Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis.

Authors: Antoine Adenis; Charles Ferté; Nicolas Penel
Journal: Invest New Drugs Date: 2009-05-08 Impact factor: 3.850

2. Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study.

Authors: K B Pittman; I N Olver; B Koczwara; D Kotasek; W K Patterson; D M Keefe; C S Karapetis; F X Parnis; S Moldovan; S J Yeend; T J Price
Journal: Br J Cancer Date: 2006-10-31 Impact factor: 7.640

Review 3. Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis.

Authors: J Lee; S Hahn; D-W Kim; J Kim; S N Kang; S Y Rha; K B Lee; J-H Kang; B-J Park
Journal: Br J Cancer Date: 2012-11-22 Impact factor: 7.640

4. Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.

Authors: K Yonemori; M Ando; M Yunokawa; T Hirata; T Kouno; C Shimizu; K Tamura; N Katsumata; A Hirakawa; K Matsumoto; Y Yamanaka; H Arioka; Y Fujiwara
Journal: Br J Cancer Date: 2008-12-16 Impact factor: 7.640

5. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site.

Authors: A Piga; R Nortilli; G L Cetto; N Cardarelli; S Luzi Fedeli; G Fiorentini; M D'Aprile; F Giorgi; A P Parziale; A Contu; R Montironi; R Gesuita; F Carle; R Cellerino
Journal: Br J Cancer Date: 2004-05-17 Impact factor: 7.640

5 in total